Ratio Examination: DocGo Inc (DCGO)’s Price-to-Cash and Price-to-Free Cash Flow

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

In the latest session, DocGo Inc (NASDAQ: DCGO) closed at $3.16 up 4.64% from its previous closing price of $3.02. In other words, the price has increased by $4.64 from its previous closing price. On the day, 1.0 million shares were traded. DCGO stock price reached its highest trading level at $3.185 during the session, while it also had its lowest trading level at $3.07.

Ratios:

For a deeper understanding of DocGo Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.09 and its Current Ratio is at 2.09. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.05.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on August 18, 2023, initiated with a Buy rating and assigned the stock a target price of $15.

On April 21, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $11.

On April 19, 2022, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $11.Deutsche Bank initiated its Buy rating on April 19, 2022, with a $11 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 13 ’24 when Bienstock Lee bought 25,000 shares for $3.15 per share. The transaction valued at 78,750 led to the insider holds 1,220,845 shares of the business.

Tendler Ely D bought 10,000 shares of DCGO for $31,300 on May 13 ’24. The General Counsel and Secretary now owns 162,933 shares after completing the transaction at $3.13 per share. On Mar 15 ’24, another insider, KATZ STEVEN, who serves as the Director of the company, bought 13,500 shares for $3.64 each. As a result, the insider paid 49,140 and bolstered with 69,534 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DCGO now has a Market Capitalization of 320948576 and an Enterprise Value of 335656416. As of this moment, DocGo’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.63, and their Forward P/E ratio for the next fiscal year is 19.57. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.50. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.46 while its Price-to-Book (P/B) ratio in mrq is 1.05. Its current Enterprise Value per Revenue stands at 0.477 whereas that against EBITDA is 6.096.

Stock Price History:

The Beta on a monthly basis for DCGO is 0.93, which has changed by -0.6255924 over the last 52 weeks, in comparison to a change of 0.2704494 over the same period for the S&P500. Over the past 52 weeks, DCGO has reached a high of $10.82, while it has fallen to a 52-week low of $2.78. The 50-Day Moving Average of the stock is -13.65%, while the 200-Day Moving Average is calculated to be -40.25%.

Shares Statistics:

For the past three months, DCGO has traded an average of 1.06M shares per day and 1177910 over the past ten days. A total of 104.06M shares are outstanding, with a floating share count of 85.31M. Insiders hold about 16.00% of the company’s shares, while institutions hold 43.84% stake in the company. Shares short for DCGO as of 1714435200 were 8676423 with a Short Ratio of 8.20, compared to 1711584000 on 10488810. Therefore, it implies a Short% of Shares Outstanding of 8676423 and a Short% of Float of 8.61.

Earnings Estimates

The current rating of DocGo Inc (DCGO) reflects the combined expertise of 7.0 analysts actively engaged in assessing its market performance.On average, analysts expect EPS of $0.06 for the current quarter, with a high estimate of $0.11 and a low estimate of $0.04, while EPS last year was -$0.02. The consensus estimate for the next quarter is $0.05, with high estimates of $0.12 and low estimates of -$0.04.

Analysts are recommending an EPS of between $0.46 and $0.05 for the fiscal current year, implying an average EPS of $0.26. EPS for the following year is $0.3, with 6.0 analysts recommending between $0.58 and $0.07.

Revenue Estimates

A total of 7 analysts believe the company’s revenue will be $166.16M this quarter.It ranges from a high estimate of $184.6M to a low estimate of $155.9M. As of the current estimate, DocGo Inc’s year-ago sales were $125.49MFor the next quarter, 7 analysts are estimating revenue of $145.27M. There is a high estimate of $184.9M for the next quarter, whereas the lowest estimate is $125.8M.

A total of 7 analysts have provided revenue estimates for DCGO’s current fiscal year. The highest revenue estimate was $736.6M, while the lowest revenue estimate was $601.3M, resulting in an average revenue estimate of $637.59M. In the same quarter a year ago, actual revenue was $624.29MBased on 6 analysts’ estimates, the company’s revenue will be $482.52M in the next fiscal year. The high estimate is $825.24M and the low estimate is $393.9M.

Most Popular

[the_ad id="945"]